SLC39A8 and malignant colon neoplasm: Knocking down SLC39A8 promoted the proliferation of different colon cancer cell lines (DLD1, HCT116, and HT29), and silencing SLC48A1 suppressed the proliferation of colon cancer cells in vitro (Figures 8C,D, Supplementary Figure S4).